Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
ZG-2305
Cat. No.:
OB0425LY-244
Appearance:
Solid
Purity:
≥95%
Identity:
Confirmed by NMR.
Size:
Add to basket
Product Overview
Description:
ZG-2305 is a small molecule inhibitor designed to target specific cell signaling pathways.
Synonyms:
2962103-54-2; ZG-2305; ZG 2305; ZG2305
CAS No.:
2962103-54-2
Formula:
C17H11Cl2N3O5
Formula Weight:
408.19
Specification
Target:
HIF/HIF prolyl-hydroxylase
Pathway:
Metabolic enzyme/Protease
Storage:
Storage at -20°C.
Applications:
ZG-2305 lowers intracellular triglyceride levels and reduces fat accumulation and can be used to study obesity and fatty liver.
